Pharmaceutical Companies

July 26, 2022

Teva Reaches Proposed $4.35 Billion Settlement of U.S. Opioid Lawsuits

(Reuters) - Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemic.
July 4, 2022

A federal judge sides with 3 major drug distributors in a landmark opioid lawsuit

CHARLESTON, W.Va. — A federal judge on Monday ruled in favor of three major U.S. drug distributors in a landmark lawsuit that accused them of causing a health crisis by distributing 81 million pills over eight years in one West Virginia county ravaged by opioid addiction.
April 6, 2022

McKesson loses bid to make insurers cover opioid defense

Judge finds lawsuits allege deliberate, not accidental, conduct. McKesson says it has spent more than $270 million on opioid legal defense
February 25, 2022

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis
March 30, 2022

Cardinal Health keeps opioid coverage fight in state court

6th Circuit cites risk of state, federal court friction. Ohio state courts are considering other opioid coverage disputes
February 25, 2022

Cardinal Health to payout billions in massive opioid lawsuit

Johnson & Johnson and its three largest drug distributors will pay a combined $26 billion to communities affected by the opioid crisis.
February 23, 2022

Corporate opioid payouts now being finalized would top $32 billion

Over the next two weeks, some of the biggest U.S. corporations accused of "turbocharging" the opioid epidemic could finalize payouts to victims and governments worth roughly $32 billion.
February 1, 2022

Native American tribes reach $590 million opioid settlement

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors